Literature DB >> 19094424

Glucosamine and chondroitin for osteoarthritis.

E C Huskisson1.   

Abstract

Osteoarthritis (OA) is a common, chronic disease that most frequently affects the knees and is a major cause of disability in the elderly. It is characterized by progressive cartilage loss, accompanied by secondary changes such as osteophyte formation and calcium deposition. Inflammatory processes are also involved, leading to stiffness and pain, for which patients seek treatment. Conventional treatment includes analgesics or non-steroidal anti-inflammatory drugs, however life-style changes should also be recommended, such as weight reduction and specific exercises. Glucosamine and chondroitin, classed as over-the-counter supplements or nutraceuticals, are regularly self-administered by patients with OA. Both agents are produced endogenously in the human body and are essential components of cartilage. This review discusses the evidence that supports the use of these agents either alone or in combination for pain relief and as disease-modifying agents in OA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19094424     DOI: 10.1177/147323000803600602

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  23 in total

1.  Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models.

Authors:  Shibing Yang; Charles B Eaton; Timothy E McAlindon; Kate L Lapane
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

Review 2.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

3.  Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal.

Authors:  Philip J Gregory; Chris Fellner
Journal:  P T       Date:  2014-06

4.  Strategies for managing osteoarthritis.

Authors:  Norman Tiong Meng Ng; Kristiann C Heesch; Wendy J Brown
Journal:  Int J Behav Med       Date:  2012-09

5.  Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review.

Authors:  Kent Stuber; Sandy Sajko; Kevyn Kristmanson
Journal:  J Can Chiropr Assoc       Date:  2011-03

6.  Total mortality risk in relation to use of less-common dietary supplements.

Authors:  Gaia Pocobelli; Alan R Kristal; Ruth E Patterson; John D Potter; Johanna W Lampe; Ann Kolar; Ilonka Evans; Emily White
Journal:  Am J Clin Nutr       Date:  2010-04-21       Impact factor: 7.045

7.  Glucosamine inhibits decidualization of human endometrial stromal cells and decreases litter sizes in mice.

Authors:  Jui-He Tsai; Maureen Schulte; Kathleen O'Neill; Maggie M-Y Chi; Antonina I Frolova; Kelle H Moley
Journal:  Biol Reprod       Date:  2013-07-25       Impact factor: 4.285

8.  Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study.

Authors:  Jessie A Satia; Alyson Littman; Christopher G Slatore; Joseph A Galanko; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

9.  Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease.

Authors:  Cristian Cerda; Miguel Bruguera; Albert Parés
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

Review 10.  Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules.

Authors:  Brady F Cress; Jacob A Englaender; Wenqin He; Dennis Kasper; Robert J Linhardt; Mattheos A G Koffas
Journal:  FEMS Microbiol Rev       Date:  2014-01-27       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.